All posts by: Michael Zand

About Michael Zand

Agilis Biotherapeutics Presents on Gene Therapy Pricing Strategies at the 2 – Business Wire (press release)

Continue reading

2018-05-02 NEWS

Business Wire (press release)

Agilis Biotherapeutics Presents on Gene Therapy Pricing Strategies at the 2
Business Wire (press release)
Agilis is advancing innovative gene therapies designed to provide long-term efficacy for patients with debilitating, often fatal, rare genetic diseases that affect the central nervous system. Agilis’ gene therapies are engineered to impart sustainable
Agilis Biotherapeutics Presents on Gene Therapy Pricing Strategies at the 2nd Annual Gene Therapy for Rare …Fort Bend Herald

all 1 news articles »